Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darton

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|July 15, 2024
Molecular Methods Enhance the Detection of Pyoderma-Related Streptococcus pyogenes and emm-Type Distribution in ChildrenJennifer N Hall, Edwin P Armitage, Elina Senghore, et al.
Molecular Pharmaceutics|December 16, 2024
Rationalizing mAb Candidate Screening Using a Single Holistic Developability ParameterLeon F Willis, Isabelle Trayton, Janet C Saunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2018
The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection StudiesMalick M Gibani, Merryn Voysey, Celina Jin, et al.
EMBO Molecular Medicine|August 31, 2019
Diagnostic host gene signature for distinguishing enteric fever from other febrile diseasesChristoph J Blohmke, Julius Muller, Malick M Gibani, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
BMJ Open|May 4, 2026
Hypothermia risk factors in patients with burns during emergency presentations: protocol for a retrospective cohort studyDhairya Deven Vayada, Maleea D Holbert, Brandon Meikle, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trialJoanna Moncrieff, Nadia Crellin, Jacki Stansfeld, et al.
Muscle & Nerve|August 14, 2023
Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trialJerry R Mendell, Zarife Sahenk, Kelly J Lehman, et al.
Frontiers in Microbiology|October 4, 2017
Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a <i>Salmonella</i> Proteome ArrayThomas C Darton, Stephen Baker, Arlo Randall, et al.
Annals of Neurology|August 4, 2023
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR)Craig M Zaidman, Crystal M Proud, Craig M McDonald, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|July 15, 2024
Molecular Methods Enhance the Detection of Pyoderma-Related Streptococcus pyogenes and emm-Type Distribution in ChildrenJennifer N Hall, Edwin P Armitage, Elina Senghore, et al.
Molecular Pharmaceutics|December 16, 2024
Rationalizing mAb Candidate Screening Using a Single Holistic Developability ParameterLeon F Willis, Isabelle Trayton, Janet C Saunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2018
The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection StudiesMalick M Gibani, Merryn Voysey, Celina Jin, et al.
EMBO Molecular Medicine|August 31, 2019
Diagnostic host gene signature for distinguishing enteric fever from other febrile diseasesChristoph J Blohmke, Julius Muller, Malick M Gibani, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
BMJ Open|May 4, 2026
Hypothermia risk factors in patients with burns during emergency presentations: protocol for a retrospective cohort studyDhairya Deven Vayada, Maleea D Holbert, Brandon Meikle, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trialJoanna Moncrieff, Nadia Crellin, Jacki Stansfeld, et al.
Muscle & Nerve|August 14, 2023
Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trialJerry R Mendell, Zarife Sahenk, Kelly J Lehman, et al.
Frontiers in Microbiology|October 4, 2017
Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a <i>Salmonella</i> Proteome ArrayThomas C Darton, Stephen Baker, Arlo Randall, et al.
Annals of Neurology|August 4, 2023
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR)Craig M Zaidman, Crystal M Proud, Craig M McDonald, et al.
Pageof 18